237 related articles for article (PubMed ID: 32716315)
21. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
24. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
25. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
[TBL] [Abstract][Full Text] [Related]
26. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
27. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
Sun L; Feng L; Cui J
Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
[TBL] [Abstract][Full Text] [Related]
29. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
31. TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma.
Wang C; Dou C; Wang Y; Liu Z; Roberts L; Zheng X
Int J Biol Sci; 2019; 15(8):1696-1711. PubMed ID: 31360112
[TBL] [Abstract][Full Text] [Related]
32. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis.
Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y
Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027
[TBL] [Abstract][Full Text] [Related]
34. E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression.
Wang Z; Sun X; Bao Y; Mo J; Du H; Hu J; Zhang X
Int J Oncol; 2017 Dec; 51(6):1639-1650. PubMed ID: 29039472
[TBL] [Abstract][Full Text] [Related]
35. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
Zhang X; Hu Y; Pan Y; Xiong Y; Zhang Y; Han M; Dong K; Song J; Liang H; Ding Z; Zhang X; Zhu H; Liu Q; Lu X; Feng Y; Chen X; Zhang Z; Zhang B
Oncogene; 2022 Mar; 41(12):1821-1834. PubMed ID: 35140331
[TBL] [Abstract][Full Text] [Related]
36. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
Azizi R; Salemi Z; Fallahian F; Aghaei M
J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
[TBL] [Abstract][Full Text] [Related]
38. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
39. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W
Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296
[TBL] [Abstract][Full Text] [Related]
40. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y
Med Oncol; 2013; 30(3):626. PubMed ID: 23761027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
